Table 2 Changes in clinical outcomes with ANOVA
Outcome | Intervention group | Control group | Main effect | Interaction effect | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Time | Group | Time × group | ||||||||
Pre | Post | Pre | Post | P-Value | F-Ratio | P-Value | F-Ratio | P-Value | F-Ratio | |
6MWT(m) | 139.55 (86.45) | 230.57 (119.72) | 71.39 (25.12) | 119.51 (48.99) | 0.000 | 83.729 | 0.005 | 9.588 | 0.931 | 0.008 |
TUG(s) | 31.32 (19.17) | 19.15 (11.73) | 45.20 (13.33) | 29.74 (7.68) | 0.000 | 56.415 | 0.029 | 5.430 | 0.379 | 0.805 |
FGA (score) | 15.33 (7.97) | 22.67 (5.49) | 10.42 (4.85) | 19.25 (4.65) | 0.000 | 91.189 | 0.078 | 3.422 | 0.385 | 0.785 |
BBS (score) | 43.92 (9.99) | 48.67 (6.47) | 28.75 (8.57) | 46.08 (5.01) | 0.000 | 86.416 | 0.006 | 9.151 | 0.000 | 28.058 |
SS-QOL (score) | 148.50 (32.82) | 159.58 (41.44) | 131.58 (24.19) | 155.17 (27.51) | 0.004 | 10.614 | 0.384 | 0.790 | 0.253 | 1.380 |